0.01750.57% ( +0.0001 )
Delay Closed: Nov 11, 16:00:00 (EDT)Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: KARYOPHARM THERAPEUTICS INC(KPTIQ) the Revenue is 33.43 M (-11.86%), Beat estimate;the EBIT is -22.53 M (+7.63%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.03B11.86%
0.03B15.12%
+0.00B3.26%
EBITExceed expectations
-0.02B7.63%
-0.03B16.15%
+0.01B23.78%
Revenue
ActualEstimateUnit: USD
Quarterly
EBIT
ActualEstimateUnit: USD
Quarterly
Net income
ActualEstimateUnit: USD
Quarterly
EPS
ActualEstimateUnit: USD
Quarterly
